Anti-human CD34 Antibody |产品详情|进口榴莲视频免费观看采购网

您好，欢迎来到榴莲视频下载地址入口生物网站！请登录注册

我的订单 | 联系榴莲视频下载地址入口 | 在线客服QQ：3012681483 | 客服电话：400-968-7988 | 工作时间：08:30-17:30

主营产品： ELISA8008APP幸福宝榴莲、抗体、补体血清、兔补体、干扰素、小鼠测温仪、进口榴莲视频免费观看、Quidel代理、Swant代理、PBL Assay Science代理

网站首页产品中心代理品牌新闻资讯资源中心关于榴莲视频下载地址入口

所在位置：首页 > 产品中心 > abmgood > abmgood产品

订购信息

上海榴莲视频下载地址入口生物科技公司

Tel:400-968-7988 021-33779008

Anti-human CD34 Antibody

品牌：Abmgood

货号：

规格：

货期：

应用：

咨询客服

立即购买加入购物车

Anti-human CD34 Antibody

商品详情参考文献相关资料

Overview	Print Version
Product Name	Anti-human CD34 Antibody
Description	mAb name/Clone: 43A1 Human CD34 is an unusual glycosylated membrane protein exclusively expressed on immature hematopoietic cells and on endothelial cells. CD34 may have a role in cell adhesion. CD34 has extensive utility for bone marrow transplantation. Antibody 43A1 recognizes a class 2 epitope of the 110 kd CD34 molecule.
Subtype	monoclonal
Application	IP,Flow Cyt,other
Raised In	mouse
Specificity	Antibody 43A1 recognizes a class 2 epitope of the 110 kd CD34 molecule (1, 2).
Immunogen	Human KG-1a tumor cells
Guarantee	abm guarantees that all our Anti-human CD34 Antibody will perform as described on this product webpage, if this is not the case we will provide you with a one-time replacement at no extra cost. Documentation and explanation of experiment conducted will be required when submitting a claim for replacement.
Properties
Formulation	Liquid
Quantity	100 μl
Clone	Monoclonal
Storage	This product is stable for several weeks at 4°C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20°C or below. Avoid cycles of freezing and thawing. Expiration date is one (1) year from date of receipt.
Storage Buffer	PBS, pH 7.4 with 0.02% sodium azide.
Concentration	1µg/ul
Purity	Protein A Purified
Isotype	IgG3 kappa
Species Reactivity	human
Specific References
Y077039 has been referenced in 1 publication. 1. H.J. BÃ¼hring, et al, (1991) Leukemia 5: 854-860. 2. Leukocyte Typing V (S.F. Schlossman, et al, eds.) Oxford University Press, Oxford, (1995) p. 840-874. 3. R.H. Collins, (1994) Stem Cells 12: 577-585. 4. T.L. Holyoake & M.J. Alcorn, (1994) Blood Reviews 8: 113-124. 5. J.P. Levesque, L.J. Bendell, et al. (2003) J Clin Invest 110: 187-196. 6. F Lanza, D.R. Sutherland, et al. (2001) 15: 1-13.